Tech Company Financing Transactions
Manus Bio Funding Round
Manus Bio, operating out of Cambridge, scored $75 million from BBGI and private investors.
Transaction Overview
Company Name
Announced On
11/19/2020
Transaction Type
Venture Equity
Amount
$75,000,000
Round
Series B
Investors
BBGI (Lead Investor)
Proceeds Purpose
The company intends to use the funds to expand its manufacturing capabilities in Augusta, GA, and to bring a number of new products in its R&D pipeline to commercialization.
Company Information
Company Status
Private & Independent
Industry
Consumer
Mailing Address
1030 Massachusetts Ave. 300
Cambridge, MA 02138
USA
Cambridge, MA 02138
USA
Phone
Website
Email Address
Overview
Chemical manufacturing is undergoing a period of transition, from an era focused on petrochemical-derived chemical synthesis and plant extraction to one which leverages the power of biotechnology and biomanufacturing. Manus Bio was founded in 2011 with the mission of developing an economical and sustainable biomanufacturing platform, particularly for accessing rare natural ingredients
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Ajikumar Parayil
Chief Technical Officer
Christine Santos
Co-Founder
Gregory Stephanopoulos
Browse more venture capital transactions:
Prev: 11/19/2020: Headway venture capital transaction
Next: 11/19/2020: Udemy venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on every notable VC transaction. VC investment data records reported here are sourced from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs